View SAPRP grants by type:

View SAPRP grants by:
Date or Investigator r


Health Care Services and Financing Grants

Grants listed by date, with most recent appearing first. Click a grant title for detailed information, including a summary and publications.

The Adoption of Pharmaceutical Technologies in Addiction Treatment, Carolyn Heinrich, Ph.D.
Medicaid and Public Funding for Buprenorphine Treatment of Opioid Dependence, David Fiellin, M.D.
Staff Quality in Methadone Treatment Programs, Tzy-Mey Kuo, Ph.D.
Reducing or Expanding Substance Use Disorder Treatment Programs: Evaluating Impact from the Health Care Decision-Maker's Perspective, Keith Humphreys, Ph.D.
Drug Treatment and Mental Health Services: Ethnic Differences in Access and Outcomes, Noosha Niv, Ph.D.
Service Delivery and Use of Evidence-Based Treatment Practice in Adolescent Substance Abuse Treatment Settings, Hannah Knudsen, Ph.D.
Drug Treatment and Mental Health Services: Access and Outcomes, Yih-Ing Hser, Ph.D.
Improving Treatment for Medicaid Beneficiaries with Co-occurring Disorders, Vince S. Thomas, Ph.D.
Understanding the Impacts of Funding Volatility on Treatment Services, Patricia Ebener,
Effects of Reductions in Oregon Health Plan Coverage of Substance Abuse and Mental Health Services on Its Most Vulnerable Citizens, Roy Gabriel, Ph.D.
Race/Ethnicity Disparities in the Availability of Support and Ancillary Services in Opioid Treatment Programs, Nancy Berkman, Ph.D.
RAND Cross-Site Evaluation of a National Demonstration Project for State Systems Improvement for Care of Individuals with Co-Occurring Substance Related and Mental Disorders, Harold Pincus, M.D.
A National Survey of Physicians' Adolescent Drug Testing Practices, Sharon Levy, M.D.
Policy Implications of Different Treatment Approaches for Individuals with Co-Occurring Substance Abuse and Mental Health Disorders, Constance Weisner, Dr.P.H., M.S.W.
Mental Health and Substance Abuse in Publicly Funded Treatment Systems, Bentson McFarland, M.D., Ph.D.
Implementing Welfare Reform: Changing Strategies for Managing Substance Abuse at the Local Level, Laura Schmidt, Ph.D., M.P.H., M.S.W.
Substance Abuse and Indian Child Welfare, Paul Spicer, Ph.D.
Cost Analysis and Operations Assessment of Community-based Alcohol and Drug Treatment Program, Yih-Ing Hser, Ph.D.
Drug Crackdowns and Illicit Drug Injectors' Health, Hannah Cooper, Sc.D.
Translating Alcohol Intervention Research into Clinical Trauma Centers, Carol Schermer, M.D., M.P.H.
A Study of Online Counseling and Internet Use Among Family Drug Court Participants, Susanna Nemes, Ph.D.
Public Financing and Treatment for Dual Disorders: A Case Study, Robin Clark, Ph.D.
A Policy Analysis of Changes in Federal Methadone Treatment Regulation, Deborah Podus, Ph.D.
Reimbursement Policy for Online Substance Abuse Treatment, Farrokh Alemi, Ph.D.
Substance Abuse Treatment for Pregnant Women Under Managed Care, Janet Mitchell, Ph.D.
Costs and Benefits of Prison-Based Treatment Plus Aftercare Drug-Abusing Offenders, Kathryn McCollister, Ph.D.
A Follow-up Study of Medicaid Chemical Dependency Patients in a Private HMO: Do High Medical Costs Come Down over Time?, Lawrence Walter, M.A.
Impact of Managed Care Contracting Arrangements on Access to Substance Abuse Services, Janet Mitchell, Ph.D.
Supplement to: Elimination of Drug and Alcohol Abuse as an Eligibility Category for SSI, Shanthi Kappagoda, M.S.
The Impact of Welfare Reform on Mothers Convicted of a Drug Offense, Carol Boyd, M.S.N., Ph.D., R.N.
Pathways to Substance Abuse Treatment for Adolescents in an HMO: Implications for Policy, Constance Weisner, Dr.P.H., M.S.W.
Welfare Reform and Substance Abuse Policy Changes: Reducing the Harm to Parents, Heroin Addicts, and Disabled Persons, Richard Speiglman, D.Crim.
The Sensitivity of Drug Abuse Treatment Demand to Copayment Levels, Anthony Lo Sasso, Ph.D.
Identifying Best Practices among Managed Care Plans that Provide Substance Abuse Treatment Services to Medicaid Recipients with Disabilities, Sara Bachman, Ph.D.
Integrated versus Referred Out Methadone Treatment: Quality and Costs, Daniel Polsky, Ph.D.
Cost Effectiveness of Prenatal/postnatal Treatment/interventions for Drug Abusing Pregnant Women, Jean Bailey, Ph.D.
Comparison of Utilization and Costs of Medicaid and non-Medicaid Chemical Dependency Patients in a Group Model HMO, Lawrence Walter, M.A.
"Parity" for Substance Abuse Benefits under Managed Care, Roland Sturm, Ph.D.
Moving Substance Users from Welfare to Work in the State of Florida: The Impact of Welfare Reform and Drug Treatment, Lisa Metsch, Ph.D.
Substance Abuse and Welfare Reform, Sheldon Danziger, Ph.D.
Mortality Follow-Up of Trauma Patients, Patricia Dischinger, Ph.D.
Developing a Foundation for Outcome Based Purchasing of Addictions Treatment, Norman Hoffmann, Ph.D.
Public Hospital Systems and Managed Care for Drug Involved Mothers and their Children, Dennis Andrulis, Ph.D., MPH
The Social Impact of Withdrawal of SSI Benefits for Drug and Alcohol Addiction, James Kahn, M.D., M.P.H.
Effects of the Elimination of SSI Drug Addiction and Alcoholism Eligibility: Phase 2, Richard Speiglman, D.Crim.
State Policies and Practices Addressing the Substance Abuse, Medicaid, and Employment Needs of Recipients of Welfare, Diane Woolis, Ed.D. Ed.D.
Impact of Terminating DA&A SSI/SSDI Benefits, Paul Goldstein, Ph.D.
Effects of the Elimination of SSI Drug Addiction and Alcoholism: Phase I, Richard Speiglman, D.Crim.
Illicit Drug Control: Criminal Justice vs. Public Health, Henry Saffer, Ph.D.
Analysis of the Cost Effectiveness of Correctional Substance Abuse Treatment Programs, Craig Love, Ph.D.
  About SAPRP  | SAPRP Staff | Questions | P: 336.286.4548 | F: 336.286.4550 

SAPRP . One Leadership Place . Greensboro, NC 27410 .